Micro-k and Advair hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micro-k (potassium chloride) and Advair hfa (fluticasone propionate; salmeterol xinafoate). Common drug interactions include throat irritation among females and international normalised ratio increased among males.

The phase IV clinical study analyzes what interactions people have when they take Micro-k and Advair hfa. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.

What is Advair hfa?

Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 69,790 Advair hfa users. Check the latest studies of Advair hfa.



On Jul, 14, 2026

21 people who take Micro-k and Advair hfa together, and have interactions are studied.

Micro-k and Advair hfa drug interactions.

What are the common drug interactions of Micro-K and Advair Hfa, by gender? *:

female:

  1. Throat irritation
  2. Abdominal pain
  3. Abscess (pus)
  4. Adverse drug reaction
  5. Anaemia (lack of blood)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Arthropathy
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

  1. International normalised ratio increased
  2. Interstitial lung disease
  3. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  4. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

What are the common drug interactions of Micro-K and Advair Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Throat irritation
  2. Vomiting
  3. Hypersensitivity
  4. Throat tightness

50-59:

  1. Hepatitis (inflammation of the liver)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Abdominal pain
  4. Abscess (pus)
  5. Adverse drug reaction
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Arthropathy
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

60+:

  1. Dizziness
  2. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Femur fracture
  7. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  8. Headache (pain in head)
  9. Insomnia (sleeplessness)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 19.05%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 14.29%
  3. Stress And Anxiety: 2 people, 9.52%
  4. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 9.52%
  5. Pain: 2 people, 9.52%
  6. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 9.52%
  7. High Blood Pressure: 2 people, 9.52%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
  9. Diabetes: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Micro-k and Advair hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micro-k and Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Advair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and fluticasone propionate; salmeterol xinafoate (the active ingredients of Micro-k and Advair hfa, respectively), and Micro-k and Advair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: